Malaria Clinical Management: SOP for Healthcare Facilities

Standard Operating Procedure: Malaria Clinical Management and Control

This Standard Operating Procedure (SOP) outlines the clinical management, diagnostic protocols, and preventive measures for malaria. Malaria remains a life-threatening disease caused by Plasmodium parasites transmitted through the bite of infected Anopheles mosquitoes. This document is designed for healthcare facilities to ensure standardized, evidence-based care, rapid diagnostic accuracy, and effective reporting to mitigate mortality and curb local transmission.

1. Initial Assessment and Triage

• Perform rapid assessment of ABCs (Airway, Breathing, Circulation) immediately upon patient presentation.
• Document clinical history, focusing on fever onset, recent travel to malaria-endemic regions, and previous malaria episodes.
• Assess for danger signs of severe malaria: inability to drink/breastfeed, vomiting, lethargy/coma, convulsions, dark urine, or respiratory distress.
• Obtain baseline vitals: Temperature, Heart Rate, Respiratory Rate, and Oxygen Saturation.
• Assign triage category based on urgency (e.g., immediate stabilization for suspected severe cases).

2. Diagnostic Testing Protocol

• Rapid Diagnostic Test (RDT): Perform an HRP2 or pLDH-based RDT for all patients presenting with fever within 30 minutes of triage.
• Microscopy: If RDT is negative but clinical suspicion remains high, prepare thick and thin blood films.
• Parasite Quantification: For positive microscopy results, calculate parasite density (parasites/µL).
• Anemia Screening: Perform a Hemoglobin (Hb) or Hematocrit (Hct) count as part of the baseline blood work.
• Documentation: Record test results in the patient chart and the facility’s Malaria Registry immediately.

3. Clinical Management and Treatment

• Uncomplicated Malaria: Administer weight-based Artemisinin-based Combination Therapy (ACT), such as Artemether-Lumefantrine, as per current national treatment guidelines.
• Severe Malaria: Initiate parenteral therapy (Intravenous Artesunate) immediately. Follow with a full course of oral ACT once the patient is able to tolerate oral medication.
• Supportive Care: Provide antipyretics for fever control, ensure adequate hydration, and monitor blood glucose levels (as hypoglycemia is a common complication of severe malaria and quinine treatment).
• Monitoring: Perform nursing rounds every 4 hours for the first 24 hours to monitor for neurological status and respiratory changes.

4. Public Health Reporting and Prevention

• Case Notification: Report all laboratory-confirmed malaria cases to the local health authority within 24 hours.
• Vector Control: Advise patients on the use of Insecticide-Treated Nets (ITNs) and the importance of indoor residual spraying.
• Patient Education: Ensure the patient or caregiver understands the importance of completing the full course of medication, even if symptoms subside.

Pro Tips & Pitfalls

• Pro Tip: Always consider "malaria-like" illness differentials. If a patient remains febrile after 48 hours of treatment, re-test and investigate for bacterial coinfections or drug resistance.
• Pro Tip: In children and pregnant women, malaria can progress rapidly; prioritize aggressive fluid management and rapid-acting antimalarial initiation.
• Pitfall: Do not delay treatment while waiting for laboratory confirmation if the patient presents with signs of severe malaria in a high-transmission setting.
• Pitfall: Over-reliance on RDTs; RDTs can occasionally provide false-negative results due to parasite gene deletion (HRP2/3). If the patient is critically ill and the RDT is negative, always verify with microscopy.

Template Document: Malaria Clinical Management: SOP for Healthcare Facilities

This Standard Operating Procedure outlines the clinical management and diagnostic protocols for malaria cases within healthcare facilities. It is intended for use by clinical staff, laboratory personnel, and public health officers to ensure standardized patient care and reporting.

• Document owner: [Department Name]
• Effective date: [Date]
• Version: [Version number]
• Applies to: [Facility Name or Department]

Roles and responsibilities

Steps

1. Screen all patients presenting with fever or history of fever using the [Triage Tool Name] to identify potential malaria cases.
2. Record the patient's temperature and vital signs in the [Electronic Health Record System] immediately upon arrival.
3. Collect a blood sample for a rapid diagnostic test or microscopy within [Number] minutes of the initial triage assessment.
4. Verify that the laboratory results are logged accurately, noting the parasite density if using microscopy, and attach them to the patient file.
5. Administer the first dose of [Antimalarial Medication Name] according to the patient's weight and clinical severity as defined in the facility guidelines.
6. Monitor the patient for adverse reactions or signs of severe malaria, such as [Symptom Name], every [Number] hours during the initial treatment phase.
7. Provide the patient with [Number] doses of follow-up medication and clear instructions on the importance of completing the full course.
8. Document the confirmed diagnosis in the facility malaria register before the end of the [Shift Name] shift.
9. Report all confirmed cases to the [Public Health Department] using the [Reporting Form Name] within [Number] hours of diagnosis.
10. Distribute [Number] insecticide-treated bed nets to the patient or their family members as part of the facility prevention program.
11. Schedule a follow-up appointment for the patient on [Date] to ensure clinical recovery and resolution of symptoms.

Record of completion

• Prepared by: [Full name]
• Reviewed by: [Full name]
• Date completed: [Date]
• Signature: ______________________
• Date signed: [Date]

FAQ

Q: Can a patient be treated for malaria if the diagnostic test is negative? A: Generally, no. Guidelines emphasize "Test, Treat, Track." However, if clinical suspicion remains extremely high and other common febrile illnesses are ruled out, clinical judgment may warrant a repeat test or referral to a higher-level facility for advanced diagnostics.

Q: Why is IV Artesunate preferred over Quinine for severe malaria? A: Clinical trials (such as the SEAQUAMAT and AQUAMAT studies) demonstrated that IV Artesunate significantly reduces mortality compared to Quinine and is associated with fewer side effects, such as hypoglycemia and arrhythmias.

Q: How do we handle malaria during pregnancy? A: Malaria in pregnancy requires specific attention. Follow the WHO or national guidelines regarding the use of specific ACTs in the first trimester vs. later trimesters and ensure the patient is enrolled in intermittent preventive treatment (IPTp) programs if available.